Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
38.86
-1.51 (-3.73%)
Mar 31, 2025, 9:55 AM EDT - Market open
Twist Bioscience Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 52.5, with a low estimate of 35 and a high estimate of 62. The average target predicts an increase of 35.12% from the current stock price of 38.86.
Analyst Consensus: Buy
* Price targets were last updated on Feb 4, 2025.
Analyst Ratings
The average analyst rating for Twist Bioscience stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $54 → $62 | Buy | Maintains | $54 → $62 | +59.57% | Feb 4, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $35 → $40 | Sell | Maintains | $35 → $40 | +2.95% | Feb 4, 2025 |
| Baird | Baird | Buy Maintains $48 → $54 | Buy | Maintains | $48 → $54 | +38.98% | Feb 4, 2025 |
| Wolfe Research | Wolfe Research | Buy Initiates $60 | Buy | Initiates | $60 | +54.42% | Dec 13, 2024 |
| TD Cowen | TD Cowen | Strong Buy Reiterates $58 | Strong Buy | Reiterates | $58 | +49.27% | Nov 26, 2024 |
Financial Forecast
Revenue This Year
383.76M
from 312.97M
Increased by 22.62%
Revenue Next Year
451.92M
from 383.76M
Increased by 17.76%
EPS This Year
-2.21
from -3.60
EPS Next Year
-1.71
from -2.21
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 398.0M | 476.6M | 588.2M | ||
| Avg | 383.8M | 451.9M | 538.2M | ||
| Low | 365.3M | 418.5M | 489.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.2% | 24.2% | 30.2% | ||
| Avg | 22.6% | 17.8% | 19.1% | ||
| Low | 16.7% | 9.0% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.89 | -1.25 | -0.78 |
| Avg | -2.21 | -1.71 | -1.31 |
| Low | -2.77 | -2.40 | -2.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.